The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Complementary medicines (10)
- (-) Non-prescription medicines (9)
- Regulatory compliance (33)
- Therapeutic goods regulation (33)
- Medicine safety (29)
- Prescription medicines (27)
- Vaping hub (19)
- Advertising (16)
- Legislation (15)
- Compliance and enforcement hub (13)
- Safety (12)
- Manufacturing (11)
- Australian Register of Therapeutic Goods (ARTG) (9)
- Import and export (8)
- Labelling and packaging (8)
- Listed medicines (8)
- Medical devices safety (8)
- Medicinal cannabis hub (6)
- Over the counter (OTC) medicines (6)
- Alert/Advisory (5)
- COVID-19 vaccines (5)
- Scheduling (national classification system) (5)
- COVID-19 (3)
- In Vitro Diagnostic medical devices (IVDs) (3)
- Weight loss products (3)
- Advisory bodies and committees (2)
- Clinical trials (2)
- Assessed listed medicines (1)
- Blood and blood components (1)
- Fees and payments (1)
- Registered complementary medicines (1)
- Shortages (1)
- Sunscreens (1)
Search
14 result(s) found, displaying 1 to 14
-
Safety updatesTCMs sold in Australia are carefully regulated to ensure safety and quality.
-
NoticesMRA GMP clearances that are expiring on 31 December 2024 will be automatically extended.
-
Safety updatesHealth professionals and consumers are advised that the oral antihistamine promethazine hydrochloride, sold as Phenergan and other generic brands, should not be used in children under 6 years of age.
-
NoticesFind out how listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 3) which commenced on 27 September 2024.
-
Media releasesWe have issued an infringement notice to the New South Wales based company for the alleged supply of a complementary medicine that was missing a mandatory warning statement.
-
NoticesInformation for manufacturers and sponsors regarding a new method for GMP inspections that will be used from 1 July 2024 and the extended validity of TGA issued GMP Certificates.
-
NoticesFind out how listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2024, which commenced on 14 June 2024.
-
NewsWe will adopt the 2021 Sunscreen Standard into therapeutic goods legislation. If you're a manufacturer or sponsor, find out what this means for you.
-
NewsThe Assessed listed medicine evidence guidelines have been updated, based on feedback, to aid sponsors in preparing their product applications.
-
Media releasesInfringement notices for $82,500 have been issued to Caruso’s Natural Health Pty Ltd, for an alleged failure to hold information or evidence to support therapeutic uses in relation to medicines.
-
NoticesFind out how listed medicine ingredients, and requirements for their use, have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2024.
-
Media releasesThe TGA has issued 2 infringement notices totalling $37,560 to Queensland-based company Akula Foods Pty Ltd for the alleged unlawful import of unregistered complementary medicines
-
Media releasesThe TGA has issued 4 infringement notices totalling $75,120 to Liquefy Health Pty Ltd for the alleged unlawful importation and advertising of unapproved complementary medicines.
-
Media releasesWe issued an infringement notice for $13,320 to the New South Wales based company Marvel Health (Australia) Pty Ltd. This was for an alleged failure to comply with a notice to provide information about a complementary (listed) medicine.